Mutations in the SLC6A8 gene lead to cerebral creatine deficiency syndrome (CCDS) with a spectrum of clinical manifestations, including severe intellectual delay, autism, epilepsy, and motor dysfunction. The gene discussed is SLC6A8; the disease is cerebral creatine deficiency syndrome.